6936-30-7 Usage
Description
(4-(DIPHENYLMETHYL)PIPERAZINYL)(PHENYLAMINO)METHANE-1-THIONE, also known as piminithione, is a chemical compound with potential therapeutic properties. It is a piperazine derivative that has been studied for its potential as an antidepressant and antipsychotic agent. Piminithione has been found to have a high affinity for serotonin and dopamine receptors in the brain, which may contribute to its potential efficacy in treating mood disorders and psychosis. Furthermore, its thione group may also provide antioxidant and neuroprotective properties. Further research is needed to fully understand the pharmacological effects and potential clinical applications of piminithione.
Uses
Used in Pharmaceutical Industry:
Piminithione is used as a potential antidepressant and antipsychotic agent for its high affinity for serotonin and dopamine receptors in the brain, which may contribute to its efficacy in treating mood disorders and psychosis.
Used in Neuroprotection:
Piminithione is used for its potential antioxidant and neuroprotective properties due to its thione group, which may provide benefits in protecting the brain from oxidative stress and neurodegenerative diseases.
Check Digit Verification of cas no
The CAS Registry Mumber 6936-30-7 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,9,3 and 6 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 6936-30:
(6*6)+(5*9)+(4*3)+(3*6)+(2*3)+(1*0)=117
117 % 10 = 7
So 6936-30-7 is a valid CAS Registry Number.
InChI:InChI=1/C24H25N3S/c28-24(25-22-14-8-3-9-15-22)27-18-16-26(17-19-27)23(20-10-4-1-5-11-20)21-12-6-2-7-13-21/h1-15,23H,16-19H2,(H,25,28)
6936-30-7Relevant articles and documents
NON-PEPTIDIC NEUROPEPTIDE Y RECEPTOR MODULATORS
-
Page/Page column 250, (2014/08/07)
The invention provides compounds that are modulators of neuropeptide Y (NPY) receptors, which can be selective inhibitors of NPY receptor Y2R. NPY receptor modulatory compounds are of the general formula Ar2-Y-Ar1-W-Ar3, wherein the variables are as defined herein. Compounds of the invention can be used for treatment of malconditions in patients wherein modulation of an NPY receptor is medically indicated, for example including drug or alcohol abuse, anxiety disorders, depression, stress-related disorders, neurological disorders, nerve degeneration, osteoporosis or bone loss, sleep/wake disorders, cardiovascular diseases, obesity, anorexia, inovulation, fertility disorders, angiogenesis, cell proliferation, learning and memory disorders, migraine and pain.
